Background
HCC
DISEASE, LIVER, HEPATOCELLULAR CARCINOMA
Liver transplantation (LT) is the treatment of choice for patients with hepatocellular carcinoma (HCC) confined to the liver who are not eligible for partial hepatic resection or ablation, while palliative therapies such as transarterial chemoembolization (TACE), radiotherapy, and systemic agents are recommended for those with more advanced disease [Preoperative imaging is relied upon not only for HCC detection but also for the determination of LT eligibility [To date, limited studies have prospectively compared the diagnostic performance of CECT and MRI for detection of HCC in LT candidates [Thus, we aimed to prospectively compare the diagnostic performance of EOB-MRI and CECT for HCC detection and transplant eligibility in pre-LT cirrhotic patients with explant histopathology correlation.